Duquesne Family Office »

Caris Life Sciences shares owned by Duquesne Family Office

Quarter-by-quarter ownership of Caris Life Sciences (CAI) shares owned by Duquesne Family Office from 13F filings

Historical chart of Duquesne Family Office investment in Caris Life Sciences

Tip: Access up to 7 years of quarterly data

All positions including Caris Life Sciences held by Duquesne Family Office consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Caris Life Sciences by Duquesne Family Office

Quarter filed Position value Share count Share price at filing
2026-03-31 $34M 1.9M 17.88

More positions owned by Duquesne Family Office

Natera (NTRA)
Ishares Msci Brazil Etf (EWZ)
Insmed Com Par $.01 (INSM)
Taiwan Semiconductor Manufac Sponsored Ads (TSM)
Invesco Exchange Traded Fd T S&p500 Eql Wgt Call Option (RSP)
Ypf Sociedad Anonima Spon Adr Cl D (YPF)
Bbb Foods Cl A Com (TBBB)
Alcoa (AA)
Newamsterdam Pharma Company Ordinary Shares (NAMS)
Sea Sponsord Ads (SE)
Stmicroelectronics N V Ny Registry (STM)
Woodward Governor Company (WWD)
Teva Pharmaceutical Inds Sponsored Ads (TEVA)
Roku Com Cl A (ROKU)
Broadcom (AVGO)

View all positions for Duquesne Family Office

Top funds holding Caris Life Sciences

Sixth Street Partners Management Company
J. H. Whitney Equity Partners VI
FMR
Coatue Management
T. Rowe Price Investment Management
Braidwell
PointState Capital
BlackRock
Neuberger Berman Group
Vanguard Portfolio Management
Vanguard Capital Management
OrbiMed Advisors
UBS Group
Thomas Stevens, CFA"
Duquesne Family Office

View all funds holding Caris Life Sciences